Trace element status in multiple sclerosis.
We compared trace element status in multiple sclerosis (MS) patients (n = 27) with and without treatment with corticosteroids and groups of healthy subjects. Concentrations of plasma ceruloplasmin, selenium, and zinc and erythrocyte (RBC) glutathione peroxidase, Se, and Zn were similar in all groups. RBC copper concentrations were significantly lower in MS patients than in control subjects (mean +/- SEM: 0.048 +/- 0.005 vs 0.060 +/- 0.002 mumol/g Hb) because of decreased RBC Cu with steroid therapy. RBC Zn-Cu ratios were significantly higher (14.9 +/- 1.0 vs 10.1 +/- 0.3) in MS patients than in control subjects, differing in both groups of MS patients. In MS and control subjects, RBC Cu correlated significantly with RBC Zn (r = 0.56, 0.49). Disease acuity and disability had no effect on trace-mineral status. These data suggest that in MS there is altered Cu and Zn homeostasis that may cause or result from the disease and is influenced by corticosteroid therapy. Systemic trace element alterations might provide clinically useful markers of MS.
Smith
D K
DK
Department of Medicine, Medical College of Georgia, Augusta 30912.
Feldman
E B
EB
Feldman
D S
DS
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D002570:Ceruloplasmin / Q000097:blood; D002648:Child; D003300:Copper / Q000097:blood; D004912:Erythrocytes / Q000032:analysis / Q000201:enzymology; D005260:Female; D005979:Glutathione Peroxidase / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D012643:Selenium / Q000097:blood; D014131:Trace Elements / Q000097:blood*; D015032:Zinc / Q000097:blood
D000305:Adrenal Cortex Hormones; D014131:Trace Elements; D003300:Copper; D005979:Glutathione Peroxidase; D002570:Ceruloplasmin; D012643:Selenium; D015032:Zinc